0000902664-21-001835.txt : 20210310 0000902664-21-001835.hdr.sgml : 20210310 20210310194524 ACCESSION NUMBER: 0000902664-21-001835 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Matrix Capital Management Company, LP CENTRAL INDEX KEY: 0001410830 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 21731420 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: C/O MATRIX CAPITAL MANAGEMENT CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-522-4948 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: C/O MATRIX CAPITAL MANAGEMENT CITY: WALTHAM STATE: MA ZIP: 02451 FORMER NAME: FORMER CONFORMED NAME: Matrix Capital Management Company, LLC DATE OF NAME CHANGE: 20070827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOEL DAVID E. CENTRAL INDEX KEY: 0001548144 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 21731421 MAIL ADDRESS: STREET 1: C/O MATRIX CAPITAL MANAGEMENT CO., LP STREET 2: 1000 WINTER STREET, SUITE 4500 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 ownership.xml X0306 4 2021-03-08 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001548144 GOEL DAVID E. C/O MATRIX CAPITAL MANAGEMENT CO., LP 1000 WINTER STREET, SUITE 4500 WALTHAM MA 02451 1 0 0 1 See Remarks 0001410830 Matrix Capital Management Company, LP 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 1 0 0 1 See Remarks Common Stock 2021-03-08 4 S 0 234295 38.2181 D 12880795 I See footnotes Common Stock 2021-03-08 4 S 0 75000 39.2155 D 12805795 I See footnotes Common Stock 2021-03-08 4 S 0 33600 39.9714 D 12772195 I See footnotes Common Stock 2021-03-08 4 S 0 71194 41.2063 D 12701001 I See footnotes Common Stock 2021-03-08 4 S 0 85911 41.6216 D 12615090 I See footnotes Common Stock 2021-03-09 4 S 0 215698 40.4238 D 12399392 I See footnotes Common Stock 2021-03-09 4 S 0 34302 41.1605 D 12365090 I See footnotes Common Stock 2021-03-10 4 S 0 25732 41.4673 D 12339358 I See footnotes Common Stock 2021-03-10 4 S 0 30268 42.3769 D 12309090 I See footnotes Common Stock 1504 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.8275 to $38.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.83 to $39.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.845 to $40.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.49 to $41.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.495, to $41.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40 to $41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.005 to $41.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41 to $42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.01 to $42.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager. The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. The Investment Manager may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Mr. Goel currently serves on the board of directors of the Issuer. Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner 2021-03-10 /s/ David E. Goel 2021-03-10